Wegovy in your second month: the 0.5mg dose explained

Step 1: why 0.25mg comes first and 0.5mg comes second

The Wegovy schedule is built in deliberate stages. The 0.25mg first-month dose is not intended to produce significant weight loss on its own; its job is to introduce semaglutide to your body at a level most people tolerate without serious nausea or disruption. Once four weeks have passed, the protocol moves to 0.5mg, still a relatively modest dose, but one where many people start to notice appetite beginning to change.

For a clearer picture of how each step slots in across the full schedule, the Wegovy dose progression guide covers every level from start to maintenance. The important thing at month two is not to rush it. Some patients, particularly those who had difficult nausea at 0.25mg, may stay at the lower level for an additional four weeks on clinical advice. That decision belongs to the prescriber, not the patient.

The 0.5mg pen arrives looking identical to the starter pen, and if you want to understand exactly what dose each device is set to deliver, the guide to Wegovy pen doses explains how to read and confirm what you have received. If you are ordering with a regulated pharmacy and have any doubt about what you have received, check the label carefully before injecting, and contact your prescriber or the pharmacy's aftercare team.

Step 2: what tends to happen in the body at 0.5mg

Semaglutide works as a GLP-1 receptor agonist, mimicking a gut hormone that slows stomach emptying and signals fullness to the brain. At 0.5mg that action becomes more noticeable than at the starter dose. Many people report that meals feel more filling, that snacking between meals drops away naturally, and that overall food interest decreases. These effects tend to build gradually over the four-week period rather than arriving all at once.

Side effects are worth discussing honestly here. The most common ones across the Wegovy programme are gastrointestinal: nausea, constipation, loose stools, or indigestion. They often reappear for a short spell after each dose step, including the move to 0.5mg, then settle. Eating smaller portions, staying well hydrated, and avoiding very fatty or spicy food during the adjustment window are the standard practical measures. For a plain summary of what the side-effect picture looks like across all doses, the Wegovy overview is a useful reference.

One question our prescribers hear regularly at this stage: "I don't feel much different yet, is that normal?" Yes, often. The full effect of any dose takes time to establish. Four weeks at 0.5mg is a minimum, not a ceiling for results.

Step 3: what your prescriber looks at before approving the next increase

Moving from 0.5mg to 1.0mg (the third-month step) is not automatic. A clinical review sits between every dose change. At nume, that review happens the same working day you request your next pen, with a GPhC-registered Independent Prescriber reading your answers directly. The about us page explains how the clinical team is structured if you want to understand who is involved.

Prescribers typically look at three things before approving a step up: whether side effects at the current dose have been tolerable, whether there are any new health changes or medicines to factor in, and whether the clinical picture supports continuing. If nausea has been severe or persistent, staying at 0.5mg for a further four weeks may be the right call. There is no clinical advantage to pushing through discomfort to reach a higher dose faster, the trial evidence underpinning Wegovy's licence was built on a gradual titration model, as published in the STEP 1 trial in the New England Journal of Medicine.

A practical note: if you order before midday on a weekday, review and dispatch can happen the same day. The pen arrives via DPD the next working day in plain, unbranded packaging, useful if, like many people, you prefer to keep your treatment private at home. The Wegovy cost page sets out what a single transparent price covers, including consultation, prescription and delivery.

Step 4: supporting the 0.5mg dose with everyday habits

The clinical trials that established Wegovy's effectiveness were conducted alongside a reduced-calorie diet and increased physical activity, not instead of them. At 0.5mg that lifestyle component starts to matter more, because the appetite reduction is becoming real enough to act on. Protein intake is particularly worth attending to: when overall food volume drops, getting enough protein helps preserve muscle mass. A registered dietitian or your prescriber can offer personalised guidance here; general advice only goes so far.

Hydration is another practical consideration. Nausea and reduced appetite can inadvertently reduce fluid intake, which compounds constipation and fatigue. Keeping water intake consistent through the day makes the adjustment period easier for most people. The full guide to the second Wegovy dose covers the practical side of this period in more detail, including injection technique and what to do if a dose is missed, always a question for the Patient Information Leaflet or your prescriber, not a general rule of thumb.

If you have questions about where you are in the schedule or whether a dose change is right for you, the right place to start is a conversation with a prescriber rather than an online forum. People further along in treatment sometimes ask whether Wegovy can be taken just once a month for maintenance, which is a good example of the kind of question best answered clinically rather than through general searching. Speak to our prescribers, it's a free consultation, and you'll have a clinical answer the same day.